Impact of Acid-Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH-Dependent Solubility, With Different Food Intake Conditions-Reference-Cited by-同舟云学术

Impact of Acid-Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH-Dependent Solubility, With Different Food Intake Conditions

Published:2017-04-21 Issue:6 Volume:6 Page:614-626
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Sun Wan¹,Klamerus Karen J.¹,Yuhas Lisa M.²,Pawlak Sylvester³,Plotka Anna⁴,O'Gorman Melissa²,Kirkovsky Leonid¹,Kosa Maha¹,Wang Diane¹

Affiliation:

1. Pfizer Inc; San Diego CA USA

2. Pfizer Inc; Groton CT USA

3. Pfizer Inc; New Haven CT USA

4. Pfizer Inc; Collegeville PA USA

Funder

Pfizer

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Reference30 articles.

1. Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug-drug interaction potential for molecular targeted agents in clinical development;Smelick;Mol Pharm,2013

2. Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?;Budha;Clin Pharmacol Ther,2012

3. Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective;Leeuwen;Lancet Oncol,2014

4. Phase I study of the effect of gastric acid pH modulators on the bioavailability of oral dasatinib in healthy subjects;Eley;J Clin Pharmacol,2009

5. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine;Kletzl;Anticancer Drugs,2015

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration;Cancer Treatment Reviews;2024-09

2. The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions;European Journal of Drug Metabolism and Pharmacokinetics;2024-08-06

3. Proton pump inhibitors decrease efficacy of palbociclib in patients with metastatic breast;Journal of Oncology Pharmacy Practice;2024-08-02

4. Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer;The Breast;2024-08

5. Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments;Critical Reviews in Oncology/Hematology;2024-08